199 related articles for article (PubMed ID: 19236769)
1. [Autologous peripheral blood stem cell transplantation combined with autologous bone marrow transplantation for treating refractory lymphoma].
Chen XL; Su H; Zhong KL; DA Y; Xiao XB; Liu J; Yu JD; Zhang WJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Feb; 17(1):155-9. PubMed ID: 19236769
[TBL] [Abstract][Full Text] [Related]
2. Rapid immunologic reconstitution following transplantation with mobilized peripheral blood stem cells as compared to bone marrow.
Talmadge JE; Reed E; Ino K; Kessinger A; Kuszynski C; Heimann D; Varney M; Jackson J; Vose JM; Bierman PJ
Bone Marrow Transplant; 1997 Jan; 19(2):161-72. PubMed ID: 9116614
[TBL] [Abstract][Full Text] [Related]
3. Addition of peripheral blood stem cells collected without mobilization techniques to transplanted autologous bone marrow did not hasten marrow recovery following myeloablative therapy.
Lobo F; Kessinger A; Landmark JD; Smith DM; Weisenburger DD; Wigton RS; Armitage JO
Bone Marrow Transplant; 1991 Nov; 8(5):389-92. PubMed ID: 1685105
[TBL] [Abstract][Full Text] [Related]
4. [Comparison of curative effect of autologous peripheral blood stem cell transplantation versus bone marrow transplantation for acute leukemia].
Zhang YZ; Zhang BL; Yao SQ; Liu HC; Lou FD; Gao CJ; Han XP; Wu XX; Zhao Y; Wang QS; Jing Y; Zhang M; Jin HJ; Shi ZJ; Da WM
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2003 Feb; 11(1):81-5. PubMed ID: 12667296
[TBL] [Abstract][Full Text] [Related]
5. Infused Autograft Absolute Lymphocyte Count Predicts Superior Survival in Diffuse Large B Cell Lymphoma Patients Post-Autologous Peripheral Blood Hematopoietic Stem Cell Transplantation: A Matched Case-Control Study.
Porrata LF; Burgstaler EA; Winters JL; Jacob E; Inwards DJ; Ansell SM; Micallef IN; Johnston PB; Villasboas J; Paludo J; Markovic SN
Transplant Cell Ther; 2021 Sep; 27(9):769.e1-769.e8. PubMed ID: 34091071
[TBL] [Abstract][Full Text] [Related]
6. Use of peripheral blood stem cells for autologous transplantation in acute myeloid leukemia patients allows faster engraftment and equivalent disease-free survival compared with bone marrow cells.
Visani G; Lemoli R; Tosi P; Martinelli G; Testoni N; Ricci P; Motta M; Gherlinzoni F; Leopardi G; Pastano R; Rizzi S; Piccaluga P; Isidori A; Tura S
Bone Marrow Transplant; 1999 Sep; 24(5):467-72. PubMed ID: 10482929
[TBL] [Abstract][Full Text] [Related]
7. Analysis of factors affecting hematopoietic recovery after autologous bone marrow transplantation for lymphoma.
Brandwein JM; Callum J; Sutcliffe SB; Scott JG; Keating A
Bone Marrow Transplant; 1990 Nov; 6(5):291-4. PubMed ID: 2291991
[TBL] [Abstract][Full Text] [Related]
8. Effect of pre-transplant cumulative doses of chemotherapeutic drugs on early and long-term hematological recovery after autologous bone-marrow transplantation for lymphoma.
Martín A; Pérez-Simón JA; Caballero MD; López-Holgado N; Vázquez L; del Cañizo MC; San Miguel JF
Haematologica; 2005 Jan; 90(1):78-85. PubMed ID: 15642673
[TBL] [Abstract][Full Text] [Related]
9. Comparison of peripheral blood stem-cell and autologous bone marrow transplantation for lymphoma patients: a case-controlled analysis of the EBMT Registry data. Lymphoma Working Party of the EBMT.
Liberti G; Pearce R; Taghipour G; Majolino I; Goldstone AH
Ann Oncol; 1994; 5 Suppl 2():151-3. PubMed ID: 7911318
[TBL] [Abstract][Full Text] [Related]
10. Engraftment with peripheral blood stem cells using noncontrolled-rate cryopreservation: comparison with autologous bone marrow transplantation.
Rosenfeld CS; Gremba C; Shadduck RK; Zeigler ZR; Nemunaitis J
Exp Hematol; 1994 Mar; 22(3):290-4. PubMed ID: 7509292
[TBL] [Abstract][Full Text] [Related]
11. Immunotherapy with interleukin 2 with or without lymphokine-activated killer cells after autologous bone marrow transplantation for malignant lymphoma: a feasibility trial.
Benyunes MC; Higuchi C; York A; Lindgren C; Thompson JA; Buckner CD; Fefer A
Bone Marrow Transplant; 1995 Aug; 16(2):283-8. PubMed ID: 7581149
[TBL] [Abstract][Full Text] [Related]
12. [Treatment of malignant lymphoma by autologous hematopoietic stem cell transplantation combined with high dose radiotherapy and chemotherapy].
Wang HQ; Cui XZ; Ren XB; Liu XM; Dai RZ; Zhang HL; Huang WY; Li W; Hao XS
Zhonghua Yi Xue Za Zhi; 2003 Jun; 83(11):948-51. PubMed ID: 12899794
[TBL] [Abstract][Full Text] [Related]
13. [Allogenic bone marrow transplantation versus autograft in acute lymphoblastic leukemia, in second remission in 113 children. Results of the Grupo Español de Transplante de Medula Niños (GETMON)].
Badell I; Ortega JJ; Muñoz A; Bureo E; Madero L; Olivé T; Cubells J; Maldonado MS; Baro J; Díaz MA
Sangre (Barc); 1996 Apr; 41(2):101-8. PubMed ID: 9045349
[TBL] [Abstract][Full Text] [Related]
14. 'Relative' chemotherapy sensitivity: the impact of number of salvage regimens prior to autologous stem cell transplant for relapsed and refractory aggressive non-Hodgkin's lymphoma.
Chen CI; Roitman D; Tsang R; Stewart AK; Keating A; Crump M
Bone Marrow Transplant; 2002 Dec; 30(12):885-91. PubMed ID: 12476281
[TBL] [Abstract][Full Text] [Related]
15. G-CSF primed peripheral blood progenitor cells in autologous bone marrow transplantation: parameters affecting bone marrow engraftment.
Bolwell BJ; Fishleder A; Andresen SW; Lichtin AE; Koo A; Yanssens T; Burwell R; Baucco P; Green R
Bone Marrow Transplant; 1993 Dec; 12(6):609-14. PubMed ID: 7511016
[TBL] [Abstract][Full Text] [Related]
16. [Combined high dose chemotherapy with autologous stem cell transplantation and total body radiotherapy for 32 malignant lymphoma patients].
Wang H; Cui X; Shao Y
Zhonghua Zhong Liu Za Zhi; 2001 Sep; 23(5):436-8. PubMed ID: 11810783
[TBL] [Abstract][Full Text] [Related]
17. Autologous bone marrow or peripheral blood stem cell transplantation followed by maintenance chemotherapy for adult acute lymphoblastic leukemia in first remission: 50 cases from a single center.
Powles R; Mehta J; Singhal S; Horton C; Tait D; Milan S; Pollard C; Lumley H; Matthey F; Shirley J
Bone Marrow Transplant; 1995 Aug; 16(2):241-7. PubMed ID: 7581142
[TBL] [Abstract][Full Text] [Related]
18. The additive effect of peripheral blood stem cells, harvested with low-dose cyclophosphamide, to autologous bone marrow reinfusion on hematopoietic reconstitution after ablative chemotherapy in breast cancer patients with localized disease.
de Graaf H; Mulder NH; Willemse PH; van der Graaf WT; Sleijfer DT; Zijlstra JG; Elias M; Sibinga CT; Vellenga E; de Vries EG
Anticancer Res; 1995; 15(6B):2851-6. PubMed ID: 8669878
[TBL] [Abstract][Full Text] [Related]
19. [Economic costs of autotransplantation of hematopoietic progenitors].
de Arriba F; Heras I; del Carmen Garcia M; Moraleda JM; Funes C; Ferrer F; Vicente V
Med Clin (Barc); 1996 Mar; 106(9):329-32. PubMed ID: 8667698
[TBL] [Abstract][Full Text] [Related]
20. Autologous bone marrow transplantation for patients with acute myeloblastic leukemia in relapse after autologous blood stem cell transplantation.
de la Rubia J; Sanz GF; Martín G; Sempere A; Picón I; Carral A; Larrea L; Martínez J; Soler MA; Bonanad S; López F; Jarque I; Sanz MA
Bone Marrow Transplant; 1996 Dec; 18(6):1167-73. PubMed ID: 8971390
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]